ELYM Climb Bio, Inc.

Nasdaq climbbio.com


$ 1.99 $ 0.00 (0 %)    

Friday, 24-Oct-2025 16:47:19 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 1.99
$ 2.03
$ 1.96 x 45
$ 2.11 x 200
$ 1.97 - $ 2.09
$ 1.05 - $ 4.68
495,558
na
134.85M
$ 0.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-25-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-06-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-07-2022 12-31-2021 10-K
16 11-08-2021 09-30-2021 10-Q
17 09-13-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 eliem-therapeutics-announces-rebranding-and-corporate-name-change-to-climb-bio-inc-will-begin-trading-on-nasdaq-under-the-trading-symbol-clym-effective-october-3rd

Name change to "Climb Bio" marks the Company's transition and focus on developing treatments for immune-mediated di...

 eliem-therapeutics-files-prospectus-relates-to-resale-from-time-to-time-of-up-to-368m-shares-of-common-stock-by-selling-stockholders

 - SEC Filing

 nasdaq-jumps-250-points-crude-oil-down-1

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday. The D...

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 eliem-therapeutics-shifts-from-neurology-with-new-found-focus-on-autoimmune-diseases-with-tenet-medicines-deal

Eliem Therapeutics will acquire Tenet Medicines, focusing on advancing TNT119, an anti-CD19 antibody for autoimmune diseases. S...

 dow-dips-100-points-carmax-earnings-miss-views

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday.

 nasdaq-gains-over-50-points-us-producer-prices-increase-in-march

U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the D...

Core News & Articles
Market-Moving News for April 11th
04/11/2024 12:31:02

RLYB: 104% | Rallybio shares are trading higher after the company announced a collaboration with Johnson & Johnson to advan...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION